Aristeia Capital’s Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 PIAI.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-215,595
Closed -$14K 715
2022
Q2
$14K Hold
215,595
﹤0.01% 656
2022
Q1
$48K Hold
215,595
﹤0.01% 649
2021
Q4
$118K Hold
215,595
﹤0.01% 568
2021
Q3
$148K Buy
215,595
+17,429
+9% +$14.4K ﹤0.01% 491
2021
Q2
$198K Buy
+198,166
New +$173K ﹤0.01% 447

Other funds holding PIAI.WS

Aristeia Capital's PIAI.WS Position: Q3 2022 in Review

Aristeia Capital sold out of Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (PIAI.WS) in Q3 2022, closing a stake of 215,595 shares — an estimated $14K sold.

Aristeia Capital first reported a position in PIAI.WS in Q2 2021 and held it in 5 quarters. The position peaked at $198K in Q2 2021. 33 funds tracked by Wall St. Rank hold PIAI.WS as of Q3 2022.

  • Aristeia Capital reported no remaining Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q3 2022 after selling out during the quarter.
  • Aristeia Capital sold 215,595 Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q3 2022, an estimated $14K.
  • Aristeia Capital first reported a position in Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q2 2021 and held it in 5 quarters.
  • Aristeia Capital's Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $198K in Q2 2021.
  • 33 funds tracked by Wall St. Rank held Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q3 2022.

Based on Aristeia Capital's 13F filing for Q3 2022, filed 14 Nov 2022.